21 May 2013
Keywords: hgs/novartis, drug, non-, inferior, pegasys, usa-based, human
Article | 16 March 2009
USA-based Human Genome Sciences has reported that its Albuferon (albinterferon alfa-2b) met the primary endpoint in ACHIEVE 1, a Phase
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 March 2009
20 May 2013
© 2013 thepharmaletter.com